estriol has been researched along with Vaginosis, Bacterial in 7 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Vaginosis, Bacterial: Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "03 mg estriol-lactobacilli combination on the vaginal ecosystem in postmenopausal breast cancer (BC) survivors on aromatase inhibitors (AI) with severe atrophic vaginitis." | 7.81 | Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| "03 mg estriol-lactobacilli combination on the vaginal ecosystem in postmenopausal breast cancer (BC) survivors on aromatase inhibitors (AI) with severe atrophic vaginitis." | 3.81 | Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donders, G | 1 |
| Bellen, G | 1 |
| Neven, P | 1 |
| Grob, P | 1 |
| Prasauskas, V | 1 |
| Buchholz, S | 1 |
| Ortmann, O | 1 |
| Senok, AC | 1 |
| Verstraelen, H | 1 |
| Temmerman, M | 1 |
| Botta, GA | 1 |
| Donders, GG | 1 |
| Van Bulck, B | 1 |
| Van de Walle, P | 1 |
| Kaiser, RR | 2 |
| Pohlig, G | 1 |
| Gonser, S | 1 |
| Graf, F | 2 |
| Parent, D | 1 |
| Bossens, M | 1 |
| Bayot, D | 1 |
| Kirkpatrick, C | 1 |
| Wilkinson, FE | 1 |
| Kuczyńska, K | 1 |
| Wołczyński, S | 1 |
| Janucik-Gacuta, M | 1 |
| Zbroch, T | 1 |
| Iosif, CS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Flourish HEC Vaginal Care System on Vaginal Microbiome in Women With Recurrent Bacterial Vaginosis[NCT05701722] | 400 participants (Anticipated) | Interventional | 2023-03-29 | Recruiting | |||
| A Multicenter, Open Label, Non-comparative, 3 Months Study to Assess the Performance and Safety of the New Medical Device Polybactum® in Reducing the Frequency of Recurrent Bacterial Vaginosis[NCT02863536] | 56 participants (Actual) | Interventional | 2016-09-08 | Completed | |||
| Pregnancy Outcomes Following Preconception Treatment of Asymptomatic Bacterial Vaginosis in an Infertility Population: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.[NCT01322971] | 2 participants (Actual) | Interventional | 2011-02-28 | Terminated (stopped due to Disease prevalence lower than expected in population.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for estriol and Vaginosis, Bacterial
| Article | Year |
|---|---|
Probiotics for the treatment of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Estriol; Female; Humans; Lactobacillus; Probiotics; Randomized C | 2009 |
Probiotics for the treatment of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Estriol; Female; Humans; Lactobacillus; Probiotics; Randomized C | 2009 |
Probiotics for the treatment of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Estriol; Female; Humans; Lactobacillus; Probiotics; Randomized C | 2009 |
Probiotics for the treatment of bacterial vaginosis.
Topics: Anti-Bacterial Agents; Clindamycin; Estriol; Female; Humans; Lactobacillus; Probiotics; Randomized C | 2009 |
2 trials available for estriol and Vaginosis, Bacterial
| Article | Year |
|---|---|
Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study.
Topics: Administration, Intravaginal; Adolescent; Adult; Bacteria, Aerobic; Estriol; Female; Freeze Drying; | 2010 |
Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Estriol; Female; Humans; Lactobacillus | 1996 |
4 other studies available for estriol and Vaginosis, Bacterial
| Article | Year |
|---|---|
Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
Topics: Administration, Intravaginal; Adult; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Candida; Ca | 2015 |
ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31, October 2001. (Replaces Technical Bulletin number 206, June 1995; Committee Opinion number 172, May 1996; Commi
Topics: Cervix Uteri; Estriol; Female; Fibronectins; Glycoproteins; Humans; Infant, Newborn; Infant, Prematu | 2001 |
[Influence of hormonal replacement therapy on bacterial vaginosis in the group of peri- and postmenopausal women].
Topics: Adult; Aged; Climacteric; Estriol; Female; Hormone Replacement Therapy; Humans; Lactobacillus; Micro | 2001 |
Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women.
Topics: Administration, Intravaginal; Aged; Atrophy; Estriol; Estrogen Replacement Therapy; Female; Humans; | 1992 |